Registration Document Including Annual Financial Report

Overview

The report describes the company's 2017 progress in resuming and internationalizing its pivotal artificial-heart study, including first human implantations in Kazakhstan and the Czech Republic. It also highlights the final phase of work on a new automated assembly plant and a €52.9 million capital increase that strengthened development funding. The company remained pre-commercial, recording no revenue because the artificial heart was still in clinical development.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2017
Period: 1 January 2017 – 31 December 2017
Publication date: 22 March 2018
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services